11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome - PubMed (original) (raw)
11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome
P M Stewart et al. J Clin Endocrinol Metab. 1995 Dec.
Abstract
A characteristic feature of the ectopic ACTH syndrome is a state of mineralocorticoid excess, although the etiology remains obscure. Some forms of endocrine hypertension, such as licorice ingestion, have been explained by cortisol acting as a mineralocorticoid in the setting of inhibition or deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme is responsible for the conversion of cortisol (F) to hormonally inactive cortisone, and its activity in vivo can be inferred from the ratio of the urinary excretion of tetrahydrocortisol (THF) and its isomer (5 alpha THF) to tetrahydrocortisone. Twenty-two patients with Cushing's syndrome (11 pituitary dependent, 9 ectopic, and 2 adrenal adenomas) and 13 controls were studied. Compared to controls. Cushing's patients had a significant increase (P < 0.001) in the excretion of all principal metabolites of F, secondary to a 5- to 6-fold increase in the cortisol secretion rate [median, 34.0 (range, 13.3-327) mg/day in Cushing's vs. 6.1 (range, 2.5-10.3) mg/day in controls]. The THF plus 5 alpha THF/tetrahydrocortisone ratio was significantly increased in Cushing's syndrome regardless of etiology [mean, 1.81 (range, 1.09-9.99) in Cushing's vs. 0.81 (range, 0.51-1.47) in controls; P < 0.001), indicative of defective 11 beta HSD activity. Furthermore, compared to patients with pituitary-dependent Cushing's, this ratio was significantly higher in patients with the ectopic ACTH syndrome (4.12 vs. 1.49; P < 0.01) and was inversely correlated with serum potassium levels (r = -0.57; P = 0.01; n = 22). One explanation for the mineralocorticoid excess state of the ectopic ACTH syndrome appears to be that cortisol gains inappropriate access to the mineralocorticoid receptor through failure of its normal metabolism by 11 beta HSD. The reason for the defective 11 beta HSD activity is unclear, but it may be secondary to substrate saturation, inhibition by other adrenal steroids, or product inhibition.
Similar articles
- Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M, Shackleton CH, Mantero F, Stewart PM. Palermo M, et al. Clin Endocrinol (Oxf). 1996 Nov;45(5):605-11. doi: 10.1046/j.1365-2265.1996.00853.x. Clin Endocrinol (Oxf). 1996. PMID: 8977758 - Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CR. Walker BR, et al. Clin Endocrinol (Oxf). 1992 Dec;37(6):483-92. doi: 10.1111/j.1365-2265.1992.tb01478.x. Clin Endocrinol (Oxf). 1992. PMID: 1337504 - 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
Stewart PM, Burra P, Shackleton CH, Sheppard MC, Elias E. Stewart PM, et al. J Clin Endocrinol Metab. 1993 Mar;76(3):748-51. doi: 10.1210/jcem.76.3.8445034. J Clin Endocrinol Metab. 1993. PMID: 8445034 - Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
Torpy DJ, Mullen N, Ilias I, Nieman LK. Torpy DJ, et al. Ann N Y Acad Sci. 2002 Sep;970:134-44. doi: 10.1111/j.1749-6632.2002.tb04419.x. Ann N Y Acad Sci. 2002. PMID: 12381548 Review. - Hypertension and the cortisol-cortisone shuttle.
Quinkler M, Stewart PM. Quinkler M, et al. J Clin Endocrinol Metab. 2003 Jun;88(6):2384-92. doi: 10.1210/jc.2003-030138. J Clin Endocrinol Metab. 2003. PMID: 12788832 Review.
Cited by
- GC/MS in Recent Years Has Defined the Normal and Clinically Disordered Steroidome: Will It Soon Be Surpassed by LC/Tandem MS in This Role?
Shackleton C, Pozo OJ, Marcos J. Shackleton C, et al. J Endocr Soc. 2018 Jul 9;2(8):974-996. doi: 10.1210/js.2018-00135. eCollection 2018 Aug 1. J Endocr Soc. 2018. PMID: 30094411 Free PMC article. Review. - Miscellaneous endocrine causes of hypertension.
Auchus RJ. Auchus RJ. Curr Cardiol Rep. 2005 Nov;7(6):418-24. doi: 10.1007/s11886-005-0059-6. Curr Cardiol Rep. 2005. PMID: 16256010 Review. - Cardiovascular risk and mortality in patients with active and treated hypercortisolism.
Li D, El Kawkgi OM, Henriquez AF, Bancos I. Li D, et al. Gland Surg. 2020 Feb;9(1):43-58. doi: 10.21037/gs.2019.11.03. Gland Surg. 2020. PMID: 32206598 Free PMC article. Review. - 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome.
Bailey MA. Bailey MA. Curr Hypertens Rep. 2017 Nov 14;19(12):100. doi: 10.1007/s11906-017-0797-z. Curr Hypertens Rep. 2017. PMID: 29138984 Free PMC article. Review. - Toward a Diagnostic Score in Cushing's Syndrome.
Braun LT, Riester A, Oßwald-Kopp A, Fazel J, Rubinstein G, Bidlingmaier M, Beuschlein F, Reincke M. Braun LT, et al. Front Endocrinol (Lausanne). 2019 Nov 8;10:766. doi: 10.3389/fendo.2019.00766. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31787931 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical